ImThera To Debut Neurostim Device For Sleep Apnea In 2010
This article was originally published in The Gray Sheet
ImThera Medical will begin a clinical trial in November of its Aura6000 neurostimulation implant to treat obstructive sleep apnea, aiming for European marketing approval by the end of 2010
You may also be interested in...
Obstructive sleep apnea device developer ImThera clarifies that 40% of OSA patients have a moderate to severe form of the condition, and 85% to 90% of OSA is tongue-based (1"The Gray Sheet" Oct. 19, 2009)
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.